V
Vipin Rai
Researcher at Banaras Hindu University
Publications - 21
Citations - 772
Vipin Rai is an academic researcher from Banaras Hindu University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 8, co-authored 16 publications receiving 403 citations.
Papers
More filters
Journal ArticleDOI
Health benefits of resveratrol: Evidence from clinical studies
Akhand Pratap Singh,Rachna Singh,Sumit Singh Verma,Vipin Rai,Catherine H. Kaschula,Pralay Maiti,Subash C. Gupta +6 more
TL;DR: The rapid metabolism and poor bioavailability have limited its therapeutic use, and the recently produced micronized resveratrol formulation called SRT501, shows promise.
Journal ArticleDOI
Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.
Shruti Mishra,Sumit Singh Verma,Vipin Rai,Nikee Awasthee,Srinivas Chava,Kam M. Hui,Alan Prem Kumar,Kishore B. Challagundla,Gautam Sethi,Subash C. Gupta +9 more
TL;DR: How the modulation of lncRNAs by phytochemicals produce therapeutic effects on cancer and other chronic diseases is discussed in this review.
Journal ArticleDOI
Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.
Subash C. Gupta,Nikee Awasthee,Vipin Rai,Srinivas Chava,Venugopal Gunda,Kishore B. Challagundla +5 more
TL;DR: The discovery of lncRNAs have provided a new type of regulation for the NF-κB signaling and thus could be explored for therapeutic interventions as well as the challenges associated with the therapeutic interventions of this crosstalk are discussed.
Journal ArticleDOI
Role of miRNAs in development and disease: Lessons learnt from small organisms.
TL;DR: How miRNAs from small organisms especially those from Drosophila and C. elegans regulate development and disease pathogenesis is the focus of this review.
Journal ArticleDOI
Targeting IκappaB kinases for cancer therapy.
Nikee Awasthee,Vipin Rai,Srinivas Chava,Palanisamy Nallasamy,Ajaikumar B. Kunnumakkara,Anupam Bishayee,Subhash C. Chauhan,Kishore B. Challagundla,Subash C. Gupta +8 more
TL;DR: The utility of IKK inhibitors for cancer therapy is discussed and it is suggested that multiple cytoplasmic and nuclear proteins distinct from NF-κB and inhibitory κB are also substrates of Ikk.